SCYX Q2 2019 Earnings — SCYNEXIS, Inc. Revenue & Financial Results | Market Cap Arena

SCYXSCYNEXIS, Inc.

$37M

Q2 2019 Earnings

Healthcare Drug Manufacturers - Specialty & Generic

Income Statement

Revenue

$57,000-10.9% YoY

Gross Profit

$57,000100.0% margin

Operating Income

-$11M-19642.1% margin

Net Income

-$8M-14742.1% margin

EPS (Diluted)

$-1.58

QoQ Revenue Growth

-10.9%

Cash Flow

Operating Cash Flow

-$8M

Free Cash Flow

-$8M

Stock-Based Comp.

$446,000

Balance Sheet

Total Assets

$41M

Total Liabilities

$31M

Stockholders' Equity

$10M

Cash & Equivalents

$19M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$57,000	$64,000	-10.9%
Gross Profit	$57,000	$64,000	-10.9%
Operating Income	-$11M	-$8M	-46.2%
Net Income	-$8M	-$11M	+21.9%